Patents by Inventor William Ripley Ballou, JR.

William Ripley Ballou, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951161
    Abstract: Methods of inducing an immune response comprising at least two administrations of an adjuvanted immunogenic composition, wherein the second administration contains reduced amounts of antigen and adjuvant.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: April 9, 2024
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: William Ripley Ballou, Jr., Arnaud Michel Didierlaurent, Robbert Gerrit Van Der Most
  • Publication number: 20200306353
    Abstract: Methods of inducing an immune response comprising at least two administrations of an adjuvanted immunogenic composition, wherein the second administration contains reduced amounts of antigen and adjuvant.
    Type: Application
    Filed: March 11, 2020
    Publication date: October 1, 2020
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley BALLOU, JR., Arnaud Michel DIDIERLAURENT, Robbert Gerrit VAN DER MOST
  • Patent number: 10688168
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition comprising an M72 related antigen and wherein a subsequent administration is delayed.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: June 23, 2020
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: William Ripley Ballou, Jr., Marie-Ange Demoitie, Marie-Noelle Renelle Donner, Nadia Ouaked, Stephane Theophile Temmerman
  • Patent number: 10624961
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition, wherein a lower dose is given in the second administration than in the first administration, and wherein the second administration may be unadjuvanted.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: April 21, 2020
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley Ballou, Jr., Arnaud Michel Didierlaurent, Robbert Gerrit Van Der Most
  • Patent number: 9700605
    Abstract: The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5-10 mg metabolizable oil, 0.5-11 mg tocol and 0.1-4 mg emulsifying agent, per human dose.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: July 11, 2017
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: William Ripley Ballou, Jr., Emmanuel Jules Hanon
  • Publication number: 20170136110
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition, wherein a lower dose is given in the second administration than in the first administration, and wherein the second administration may be unadjuvanted.
    Type: Application
    Filed: April 2, 2015
    Publication date: May 18, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: William Ripley BALLOU, JR., Arnaud Michel DIDIERLAURENT, Robbert Gerrit VAN DER MOST
  • Publication number: 20170112914
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition comprising an M72 related antigen and wherein a subsequent administration is delayed.
    Type: Application
    Filed: April 2, 2015
    Publication date: April 27, 2017
    Inventors: William Ripley BALLOU, JR., Marie-Ange DEMOITIE, Marie-Noelle Renelle DONNER, Nadia OUAKED, Stephane Theophile TEMMERMAN
  • Publication number: 20150359863
    Abstract: The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5-10 mg metabolisable oil, 0.5-11 mg tocol and 0.1-4 mg emulsifying agent, per human dose.
    Type: Application
    Filed: January 9, 2015
    Publication date: December 17, 2015
    Inventors: William Ripley BALLOU, JR., Emmanuel Jules HANON
  • Publication number: 20120164178
    Abstract: The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae antigen and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5-10 mg metabolisable oil, 0.5-11 mg tocol and 0.1-4 mg emulsifying agent, per human dose.
    Type: Application
    Filed: April 16, 2009
    Publication date: June 28, 2012
    Inventors: William Ripley Ballou, JR., Emmanuel Jules Hanon
  • Publication number: 20100183667
    Abstract: The present invention provides an immunogenic composition comprising an antigen or antigen composition and an adjuvant composition comprising an oil in water emulsion, wherein said oil in water emulsion comprises 0.5-10 mg metabolisable oil, 0.5-11 mg tocol and 0.1-4 mg emulsifying agent, per human dose.
    Type: Application
    Filed: October 10, 2007
    Publication date: July 22, 2010
    Inventors: William Ripley Ballou, JR., Emmanuel Jules Hanon